James L. Michel - Waban MA Dennis L. Kasper - Newton Centre MA Frederick M. Ausubel - Newton MA Lawrence C. Madoff - Boston MA
Assignee:
The General Hospital Corporation Brigham and Womens Hospital - Boston MA
International Classification:
A61K 3909
US Classification:
4241901, 530350
Abstract:
A vaccine capable of protecting a recipient from infection caused by group B. The vaccine provides polysaccharide-protein moieties and contain (a) a group B polysaccharide conjugated to (b) a functional derivative of a group B C protein alpha antigen that retains the ability to elicit protective antibodies against group B. The vaccine may contain only one type of such polysaccharide-protein unit or may contain a mixture of more than one type of unit.
Virulence-Associated Nucleic Acid Sequences And Uses Thereof
Frederick Ausubel - Newton MA Howard M. Goodman - Newton MA Laurence G. Rahme - Brookline MA Man-Wah Tan - Somerville MA Hui Cao - Malden MA Eliana Drenkard - Cambridge MA John Tsongalis - Southbridge MA
Assignee:
The General Hospital Corporation - Boston MA
International Classification:
C12Q 100
US Classification:
435 4, 530350
Abstract:
Disclosed are bacterial virulence polypeptides and nucleic acid sequences (e. g. , DNA) encoding such polypeptides, and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing such polypeptides to screen for antibacterial or bacteriostatic compounds.
Methods Of Screening Compounds Useful For Prevention Of Infection Or Pathogenicity
Screening procedures are disclosed for identifying compounds useful for inhibiting infection or pathogenicity. Methods are also disclosed for identifying pathogenic virulence factors.
Disclosed herein are methods and kits for determining whether a nucleic acid sequence includes a particular allele of a polymorphic sequence. These methods and kits focus on two sets of primers that are specific for an allele and are contacted with a nucleic acid sequence. One primer in each set is complementary to the polymorphic sequence at its 3â-terminal nucleotide and contains one or more mismatches in the five nucleotide adjacent to the 3â terminus. The two sets of primers preferentially amplify methods are used to identify single nucleotide polymorphisms, for example, for genomic mapping purpose.
Methods Of Screening Compounds Useful For Prevention Of Infection Or Pathogenicity
Frederick M. Ausubel - Newton MA, US Stephen B. Calderwood - Wellesley MA, US Eleftherios Mylonakis - Boston MA, US Andrew Diener - Cambridge MA, US Julia Plotnikova - Quincy MA, US Costi D. Sifri - Quincy MA, US Laurence G. Rahme - Brookline MA, US Man-Wah Tan - Somerville MA, US Gary B. Ruvkun - Newton MA, US Georg Jander - Ithaca NY, US Jacqueline Heard - San Mateo CA, US
Screening procedures are disclosed for identifying compounds useful for inhibiting fungal infection or pathogenicity. Methods are also disclosed for identifying fungal pathogenic virulence factors.
Salicylic Acid Biosynthetic Genes And Uses Thereof
Mary C. Wildermuth - Cambridge MA, US Frederick M. Ausubel - Newton MA, US Julia Dewdney - Newton MA, US
Assignee:
The General Hospital Corporation - Boston MA
International Classification:
A01H 5/00 A01N 63/04
US Classification:
424 935, 800301
Abstract:
The invention provides methods for inducing or increasing disease resistance in a plant. The invention also features methods of using a plant having a mutation in an inducible isochorismate synthase to determine if the success of a pathogen in infecting a plant is affected by a plant disease resistance pathway involving isochorismate synthase.
Methods For Screening And Identifying Host Pathogen Defense Genes
Frederick M. Ausubel - Newton MA, US Rhonda Feinbaum - Arlington MA, US Man Wah Tan - Palo Alto CA, US Genviève Alloing - Nice, FR Dennis Kim - Belmont MA, US
Assignee:
The General Hospital Corporation - Boston MA
International Classification:
A01K 67/033
US Classification:
800 8, 800 9, 424 91, 424 92
Abstract:
Disclosed are methods for identifying nematodes having enhanced susceptibility to a pathogen; for identifying pathogen defense response genes; and for identifying compounds that enhances a host's defense response to a pathogen.
Methods Of Screening Compounds Useful For Prevention Of Infection Or Pathogenicity
Frederick M. Ausubel - Newton MA, US Laurence G. Rahme - Brookline MA, US Man-Wah Tan - Somerville MA, US Gary B. Ruvkun - Newton MA, US Annegien Broeks - Amsterdam, NL Ronald H. A. Plasterk - Bussam, NL Georg Jander - Cambridge MA, US Jacqueline Heard - San Ramon CA, US
Assignee:
The Netherlands Cancer Institute - Amsterdam The General Hospital Corporation - Boston MA
Screening procedures are disclosed for identifying compounds useful for inhibiting infection or pathogenicity. Methods are also disclosed for identifying pathogenic virulence factors.